285 filings
15-12G
IMVIQ
IMV Inc.
22 Sep 23
Securities registration termination
4:22pm
F-10POS
IMVIQ
IMV Inc.
22 Sep 23
Automatic registration of securities (post-effective amendment, Canada)
4:19pm
F-10POS
IMVIQ
IMV Inc.
22 Sep 23
Automatic registration of securities (post-effective amendment, Canada)
4:19pm
F-10POS
IMVIQ
IMV Inc.
22 Sep 23
Automatic registration of securities (post-effective amendment, Canada)
4:19pm
S-8 POS
IMVIQ
IMV Inc.
22 Sep 23
Registration of securities for employees (post-effective amendment)
4:16pm
S-8 POS
2hyfdee
22 Sep 23
Registration of securities for employees (post-effective amendment)
4:16pm
S-8 POS
uc58f6
22 Sep 23
Registration of securities for employees (post-effective amendment)
4:16pm
S-8 POS
ba9pilfd
22 Sep 23
Registration of securities for employees (post-effective amendment)
4:15pm
S-8 POS
wmrbbixzl5r
22 Sep 23
Registration of securities for employees (post-effective amendment)
4:15pm
6-K
1ucl3 0iv58n
26 Jul 23
IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process
2:34pm
25-NSE
ngs3ukgidp74 zmm
10 Jul 23
Exchange delisting
6:04am
6-K
tg5uno8t3vr8x8
8 May 23
IMV Receives NASDAQ Delisting Notice
4:54pm
6-K
whwa3tm os4mkhb
31 Mar 23
IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
4:23pm
6-K
q2hmr36gh
27 Mar 23
IMV Inc. Announces Changes to Its Board of Directors
8:49pm
6-K
k4s e1qd2
16 Mar 23
IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results
7:45am
20-F
e069di iz9
16 Mar 23
Annual report (foreign)
7:08am
6-K
srirrla7ji 6950ejq
9 Mar 23
Report of Foreign Private Issuer for the Month of March, 2023
12:23pm
6-K
brq i5ep57zihka3u8
13 Feb 23
IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial
10:09am
6-K
lf1vt7yd73x3lufasr
9 Jan 23
IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S
9:58am
6-K
tcjzvvswzgvo77psc3
22 Dec 22
Current report (foreign)
4:18pm